Chula Researchers Discover "Highly Effective Antibodies against COVID-19," Leading to "COVITRAP Nasal Spray" to Curb Infection at the Start
BANGKOK, May 24, 2023 /PRNewswire/ --A research team at the Center of Excellence in Systems Biology, Faculty of Medicine, Chulalongkorn University, has identified "highly effective antibodies against COVID-19" from the human body. These antibodies have been developed into an innovation called "COVITRAP," the world's first nasal spray that traps and inhibits the COVID-19 virus using antibodies. This spray has been certified as a medical device, and the team is confident in its efficacy for dealing with COVID-19 alongside other preventive measures. Although preventive mea...